Published by Emerging Technologies Laboratory · via ETL Newswire
Science· 

Bonn Researchers Reset Epigenetic Clock 60 Years in Lab-Grown Brain Stem Cells

A study in Aging Cell shows that blood cells from an 80-year-old donor, reprogrammed into neural stem cells, acquired a molecular age signature below 20, but the effect was measured in a dish, not a living body.

By Dr. Maya Iyer, Staff Reporter · Science Desk

German researchers have reprogrammed red blood cell precursors from an 80-year-old donor directly into neural stem cells, and in doing so measured a reset of the cells' epigenetic age to below 20 years. The findings, published in the peer-reviewed journal Aging Cell under the title describing protracted fate acquisition and epigenetic de-aging during induced neural stem cell conversion of human blood cells, add a notable data point to the reprogramming field, though several caveats apply before anyone calls it a path to reversing aging in people.

The key mechanism here is direct conversion. Most reprogramming protocols take a donor cell, first push it all the way back to a pluripotent induced stem cell, a state where it could theoretically become almost any cell type, and then guide it forward into the target lineage. The Bonn team, led by Prof. Oliver Brüstle, director of the Institute of Reconstructive Neurobiology at the University Hospital of Bonn, skipped that intermediate step entirely. They took erythroid progenitor cells and converted them straight into induced neural stem cells, bypassing the pluripotent stage.

That shortcut turned out to produce something scientifically useful on its own: a slower, more trackable rejuvenation process. In conventional two-step protocols, the epigenetic reset happens fast and is difficult to dissect. In the Bonn approach, because the cells never passed through full pluripotency, the epigenetic clocks, the molecular markers researchers use to estimate biological rather than chronological age, were reset gradually. The team was able to track the process for more than 100 days, according to the University of Bonn's announcement reviewed by ScienceAlert. That observational window is the part of this paper that may prove most durable.

The raw result is attention-grabbing: cells derived from an 80-year-old donor emerged from the conversion with a molecular age reading below 20 years. According to reporting reviewed by Bioengineer.org on the Aging Cell paper, the reduction amounts to roughly six decades on the epigenetic clock.

Here's where the limitations matter. This is a cell-culture experiment. There is one reported donor. The rejuvenation is measured by epigenetic clock algorithms, tools that are themselves still being validated and that do not map cleanly onto organismal aging or clinical outcomes. The paper does not claim, and the data can't support, that the same reset would occur in vivo, or that neurons derived from these cells would function equivalently to those from a young brain. The researchers note the work may help scientists study age-related neurological conditions including Alzheimer's, but that's a research application, not a therapeutic one.

The study was carried out by groups from the University Hospital of Bonn, the University of Bonn, and RWTH Aachen University, with funding from the European Union's Horizon 2020 program, the German Research Foundation, and the Federal Ministry of Research, Technology, and Space, according to the Bioengineer.org writeup of the paper. The work was published in Aging Cell on October 3 and drew a wave of secondary coverage in mid-to-late October.

What the paper genuinely offers is a new experimental model: a slow, observable version of epigenetic rejuvenation that can be studied step by step. If follow-up work can identify which molecular events during that 100-plus-day window actually drive the age reset, that's useful. Whether it ever translates to something a patient would experience is a different question entirely, and this paper doesn't answer it.

Sources cited:
- Aging Cell (Berg et al., 2026) via University of Bonn announcement (https://www.uni-bonn.de/en/news/211-2026)
- Bioengineer.org coverage of Aging Cell paper (https://bioengineer.org/blood-cells-from-80-year-olds-rejuvenated-into-brain-cells-with-molecular-age-under-20/)
- ScienceAlert (https://www.sciencealert.com/old-blood-cells-have-been-transformed-into-brain-stem-cells-that-get-younger-as-they-age)
- Government Scientific Source summary (https://resources.govsci.com/scientists-reverse-60-years-cellular-aging/)
- ScienceDaily (University of Bonn release) (https://www.sciencedaily.com/releases/2026/10/261020085013.htm)

Reporting by Dr. Maya Iyer, Staff Reporter, for the Science desk · ETL Newswire staff
Read more at the source

This release was originally distributed via ETL Newswire. Visit Aging Cell (Berg et al., 2026) via University of Bonn announcement for the full story, related releases, and contact information.

Visit Aging Cell (Berg et al., 2026) via University of Bonn announcement →